Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma: Is Chemotherapy a Factor?
β Scribed by Dan S. Gombos; John Hungerford; David H. Abramson; Judith Kingston; Guillermo Chantada; Ira J. Dunkel; Celia B.G. Antoneli; Mark Greenwald; Barret G. Haik; Carlos A. Leal; Aurora Medina-Sanson; Amy C. Schefler; Gavivann Veerakul; Regina Wieland; Norbert Bornfeld; Mathew W. Wilson; Christopher Bing On Yu
- Book ID
- 116804540
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 104 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0161-6420
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Leukostasis is a relatively uncommon but potentially catastrophic complication of acute myelogenous leukemia (AML). Prompt leukoreduction is considered imperative to reduce the high mortality rate in this condition. Leukapheresis, usually associated with chemotherapy, is an established
## Abstract Sera of eight unselected adult patients with acute myelogenous leukemia obtained before and after chemotherapy were repeatedly tested for specific complementβdependent cytotoxicity against autochthonous peripheral white blood cells from the acute leukemia stage and from the remission st